Market Overview:
The global diabetes lancing devices market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, rising awareness about diabetes and its complications, and technological advancements in lancing devices. Based on type, the global diabetes lancing devices market is segmented into adjustable lancing device and non-adjustable lancing device. The adjustable lancing device segment is expected to grow at a higher CAGR than the non-adjustable lancing device segment during the forecast period from 2018 to 2030. This can be attributed to the advantages offered by adjustable lancets such as customizable depth of penetration and lesser pain as compared with non-adjustable ones. Based on application, the global diabetes mellitus (DM) Devices Market is divided into household applications and commercial applications segments.
Product Definition:
A diabetes lancing device is a medical instrument that is used to prick the skin in order to draw blood for testing. The main purpose of a diabetes lancing device is to make it easier and less painful for people with diabetes to obtain blood samples for testing their blood sugar levels.
Adjustable Lancing Device:
An adjustable lancing device is a medical device used for the withdrawal of blood from patients. It consists of a handle, which is connected to an arm or tube. The other end of the arm or tube is fitted with a sharp point that can pierce the skin easily and quickly draw blood samples required by doctors during diagnosis and treatment procedures.
Non-adjustable Lancing Device:
Non-adjustable lancing device is a medical device used for the administration of insulin through injection. It is also known as manual lancet or stickman, which can be characterized by its simplicity and ease of use. The most common usage of non-adjustable lancing devices includes diabetes testing and self-monitoring blood glucose (SMBG) application.
Application Insights:
In 2017, the household application segment dominated the market for diabetes lancing devices and this trend is expected to continue over the forecast period. The growing number of geriatric population across the world, especially in Europe and North America is expected to drive demand for these devices in household applications. In addition, increasing awareness about hygienic practices among people living with diabetes is also likely to contribute towards segment growth.
The commercial application segment was valued at USD 281.3 million in 2017 owing to rising adoption of these products by medical professionals for various therapeutic purposes such as wound treatment or injection site pain management among others. Furthermore, companies such as Medtronic have been working closely with hospitals & healthcare providers offering advanced training on lancing devices along with its companion software applications that help patients track their blood glucose levels more effectively resulting in increased adoption by medical professionals across the globe which will further fuel demand over the forecast period (see details below).
Regional Analysis:
North America dominated the global market in 2017 owing to high prevalence of diabetes and presence of major players. In addition, availability of advanced products for self-diagnosis is also expected to drive the regional market over the forecast period. Asia Pacific region is anticipated to witness lucrative growth during the forecast period due to increasing cases of diabetes and awareness about lancing devices among people. Moreover, rising disposable income will also contribute towards regional growth over next eight years.
The key companies in this space are BD; Accu-Chek Inc.; Roche Diabetes Care GmbH & Co., KG; Novo Nordisk A/S; Sanofi SA; Abbott Laboratories Inc.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is primarily due to the changing lifestyle and dietary habits of people across the world. As a result, there is an increased demand for diabetes lancing devices as they help in monitoring blood glucose levels effectively.
- Technological advancements: Diabetes lancing devices are witnessing rapid technological advancements, with newer and more innovative products being launched in the market on a regular basis. This has helped to boost their popularity among consumers and has led to an increase in their adoption rates.
- Rising awareness about diabetes: There is a growing awareness about diabetes among people all over the world, thanks to various health campaigns conducted by governments as well as non-profit organizations globally. This has resulted in an increase in demand for diagnostic tools such as diabetes lancing devices, which can help individuals keep track of their blood sugar levels easily and effectively .
Scope Of The Report
Report Attributes
Report Details
Report Title
Diabetes Lancing Devices Market Research Report
By Type
Adjustable Lancing Device, Non-adjustable Lancing Device
By Application
Household, Commercial
By Companies
Roche, LifeScan, Abbott, Ascensia, B. Braun, Terumo, ARKRAY, Trividia Health, SANNUO, GMMC, BIONIME
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
225
Number of Tables & Figures
158
Customization Available
Yes, the report can be customized as per your need.
Global Diabetes Lancing Devices Market Report Segments:
The global Diabetes Lancing Devices market is segmented on the basis of:
Types
Adjustable Lancing Device, Non-adjustable Lancing Device
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Household, Commercial
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- LifeScan
- Abbott
- Ascensia
- B. Braun
- Terumo
- ARKRAY
- Trividia Health
- SANNUO
- GMMC
- BIONIME
Highlights of The Diabetes Lancing Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Adjustable Lancing Device
- Non-adjustable Lancing Device
- By Application:
- Household
- Commercial
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diabetes Lancing Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A diabetes lancing devices is a medical device that uses a small, sharp object to pierce the skin and inject insulin into the body.
Some of the major companies in the diabetes lancing devices market are Roche, LifeScan, Abbott, Ascensia, B. Braun, Terumo, ARKRAY, Trividia Health, SANNUO, GMMC, BIONIME.
The diabetes lancing devices market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diabetes Lancing Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diabetes Lancing Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diabetes Lancing Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diabetes Lancing Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diabetes Lancing Devices Market Size & Forecast, 2018-2028
4.5.1 Diabetes Lancing Devices Market Size and Y-o-Y Growth
4.5.2 Diabetes Lancing Devices Market Absolute $ Opportunity
Chapter 5 Global Diabetes Lancing Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Diabetes Lancing Devices Market Size Forecast by Type
5.2.1 Adjustable Lancing Device
5.2.2 Non-adjustable Lancing Device
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Diabetes Lancing Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Diabetes Lancing Devices Market Size Forecast by Applications
6.2.1 Household
6.2.2 Commercial
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diabetes Lancing Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diabetes Lancing Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Diabetes Lancing Devices Analysis and Forecast
9.1 Introduction
9.2 North America Diabetes Lancing Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Diabetes Lancing Devices Market Size Forecast by Type
9.6.1 Adjustable Lancing Device
9.6.2 Non-adjustable Lancing Device
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Diabetes Lancing Devices Market Size Forecast by Applications
9.10.1 Household
9.10.2 Commercial
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Diabetes Lancing Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Diabetes Lancing Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Diabetes Lancing Devices Market Size Forecast by Type
10.6.1 Adjustable Lancing Device
10.6.2 Non-adjustable Lancing Device
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Diabetes Lancing Devices Market Size Forecast by Applications
10.10.1 Household
10.10.2 Commercial
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Diabetes Lancing Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Diabetes Lancing Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Diabetes Lancing Devices Market Size Forecast by Type
11.6.1 Adjustable Lancing Device
11.6.2 Non-adjustable Lancing Device
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Diabetes Lancing Devices Market Size Forecast by Applications
11.10.1 Household
11.10.2 Commercial
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Diabetes Lancing Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Diabetes Lancing Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Diabetes Lancing Devices Market Size Forecast by Type
12.6.1 Adjustable Lancing Device
12.6.2 Non-adjustable Lancing Device
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Diabetes Lancing Devices Market Size Forecast by Applications
12.10.1 Household
12.10.2 Commercial
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Diabetes Lancing Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Diabetes Lancing Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Diabetes Lancing Devices Market Size Forecast by Type
13.6.1 Adjustable Lancing Device
13.6.2 Non-adjustable Lancing Device
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Diabetes Lancing Devices Market Size Forecast by Applications
13.10.1 Household
13.10.2 Commercial
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diabetes Lancing Devices Market: Competitive Dashboard
14.2 Global Diabetes Lancing Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 LifeScan
14.3.3 Abbott
14.3.4 Ascensia
14.3.5 B. Braun
14.3.6 Terumo
14.3.7 ARKRAY
14.3.8 Trividia Health
14.3.9 SANNUO
14.3.10 GMMC
14.3.11 BIONIME
